Lyell Immunopharma Stock (NASDAQ: LYEL) stock price, news, charts, stock research, profile.
You can purchase shares of Lyell Immunopharma (NASDAQ:LYEL) through any online brokerage.
Other companies in Lyell Immunopharma’s space includes: Macrogenics (NASDAQ:MGNX), Innate Pharma (NASDAQ:IPHA), 4D Molecular Therapeutics (NASDAQ:FDMT), Voyager Therapeutics (NASDAQ:VYGR) and Zentalis Pharma (NASDAQ:ZNTL).
Lyell Immunopharma has a consensus price target of $2.75.
The stock price for Lyell Immunopharma (NASDAQ: LYEL) is $0.7035 last updated February 21, 2025 at 6:48 PM EST.
There are no upcoming dividends for Lyell Immunopharma.
Lyell Immunopharma’s Q1 earnings are confirmed for Monday, May 5, 2025.
There is no upcoming split for Lyell Immunopharma.
Lyell Immunopharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.